Overview

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Status:
Completed

Trial end date:
2014-11-01

Target enrollment:

Participant gender:

Summary

This study is designed to investigate the short- and long-term effects of perampanel on cognition, growth, and development in adolescents.

Phase:

Phase 2

Details

Lead Sponsor:

Eisai Inc.